Back to search

Biofortuna Limited

06514391

active
Private Limited Company
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

2 TENTH AVENUE, DEESIDE, CH5 2UA
Incorporated 26/02/2008

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

21100
Manufacture of basic pharmaceutical products
72110
Research and experimental development on biotechnology
74909
Other professional, scientific and technical activities
86900
Other human health activities

Officers

Mr Mark Gordon Delap Hurley

director · Since 07/08/2008

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 68

Also on 24 other boards

Dr Nicholas Watson Ash

director · Since 29/04/2019

CEO

BRITISH · ENGLAND · Age 56

Also on 3 other boards

Dr Nicholas Ivor Leaves

director · Since 29/04/2019

OPERATIONS DIRECTOR

BRITISH · ENGLAND · Age 59

Also on 3 other boards

Mr Stephen Mcguinness

director · Since 02/09/2024

DIRECTOR

IRISH · ENGLAND · Age 40

Also on 6 other boards

Persons with Significant Control

Foresight Enterprise Vct Plc

25–50% shares
25–50% votes

The Shard, London Bridge Street, London, SE1 9SG

Reg: 03506579 · Companies Registry For England & Wales · Limited Company

Notified 18/07/2017

Charges1 outstanding

Charge
outstanding

DBW INVESTMENTS (3) LIMITED

Created 01/04/2026Registered 07/04/2026
charge
satisfied

CATAPULT GROWTH FUND LIMITED PARTNERSHIP

Created 18/01/2011Registered 02/02/2011Satisfied 31/03/2012
charge
satisfied

CATAPULT GROWTH FUND LIMITED PARTNERSHIP AS SECURITY TRUSTEE

Created 11/05/2010Registered 15/05/2010Satisfied 31/03/2012
charge
satisfied

LIVERPOOL SEED FUND LIMITED PARTNERSHIP AND ALLIANCE FUND MANAGERS NOMINEES LIMITED

Created 26/06/2008Registered 02/07/2008Satisfied 31/03/2012

CompanyRankvs 176+ SIC 21100 peers
59

Financial strength92th percentile among SIC peers · 23/25
Employees27th percentile among SIC peers · 4/15
LiquidityCurrent ratio 1.27× · 12/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Lofthouse Of Fleetwood Limited
90
2West Pharmaceutical Services Cornwall Limited
90
3Dr. Reddy'S Laboratories (Eu) Limited
90
4Mw Encap Limited
90
5Rsr Limited
90
6Aura-Soma Products Limited
89
7Tcs Biosciences Limited
89
8Pharmapac (U.K.) Limited
89
9Onyx Scientific Limited
89
10International Scientific Supplies Limited
89
176Biofortuna Limited
69
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees4/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£2.2M

Balance sheet strength

Cash

£804k

Cash in the bank

Net Current Assets

£419k

Working capital

Current Assets

£2.0M

Current Liabilities

£1.5M

Fixed Assets

£1.8M

Debtors

£1.1M

0avg. employees-29

Balance Sheet

Intangible assets£443k
Assets less current liabilities£2.3M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20251.27-£997k
20242.48-£933k
20233.14-£952k
20223.66-£2.6M
2021Infinity+£7.2M
20201.60—

Derived from filed accounts. Not audited figures.